TP53 and renal fibrosis: Previous studies have confirmed that P53 deacetylation alleviates renal fibrosis induced by calcium oxalate crystals by inhibiting ferroptosis, suggesting that SIRT1-mediated P53 deacetylation is a potential target for treating renal fibrosis (Mao et al., 2019).